Literature DB >> 27915263

C-reactive protein and risk of atrial fibrillation in East Asians.

Chang Hee Kwon1, Jung Gyu Kang2, Hyun Jong Lee3, Nan Hee Kim4, Joo-Wook Sung5, EunSun Cheong5, Ki-Chul Sung5.   

Abstract

AIMS: Inflammation has been suggested to play a role in the pathogenesis of atrial fibrillation (AF). It is uncertain whether C-reactive protein, a robust inflammatory marker, is associated with AF incidence in Asians with lower levels of C-reactive protein compared with western population. This study aimed to determine the association between C-reactive protein and risk of AF in a large population of Koreans. METHODS AND
RESULTS: A total of 402 946 Koreans were enrolled in a health screening programme from January 2002 to December 2013. Among them, 210 208 subjects were analysed during the mean follow-up of 4.59 years (1 062 513 person-years). Atrial fibrillation was identified by electrocardiography at every visits. Atrial fibrillation was identified in 561 subjects (0.1%) at baseline. The median (inter-quartile) baseline C-reactive protein levels were higher in subject with AF than in those without AF [0.9 mg/L (0.4-0.9) vs. 0.4 mg/L (0.2-1.0), P < 0.001]. Subjects in the highest quartile of C-reactive protein had more AF than those in the lowest quartile [adjusted odds ratio (OR) 2.02, 95% confidence interval (CI) 1.45-2.81; P< 0.001]. During a mean follow-up of 4.59 years, AF developed in 261 subjects (0.1%). The highest quartile of baseline C-reactive protein had a 1.68-fold (95% CI 1.06-2.67) increased risk of AF than the lowest quartile in multivariate Cox regression analysis.
CONCLUSION: Baseline C-reactive protein levels are significantly associated with the prevalence of AF and the risk of AF in Korean populations even C-reactive protein concentrations are substantially lower than reported in white populations. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; C-reactive protein; Inflammation; Risk

Mesh:

Substances:

Year:  2017        PMID: 27915263     DOI: 10.1093/europace/euw298

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

Review 1.  Applications of Graphene Quantum Dots in Biomedical Sensors.

Authors:  Bhargav D Mansuriya; Zeynep Altintas
Journal:  Sensors (Basel)       Date:  2020-02-16       Impact factor: 3.576

Review 2.  Advances in aptamer-based sensing assays for C-reactive protein.

Authors:  Ming-Qing Tang; Jing Xie; Liang-Ming Rao; Ya-Jie Kan; Pei Luo; Lin-Sen Qing
Journal:  Anal Bioanal Chem       Date:  2021-09-28       Impact factor: 4.142

Review 3.  Graphene Quantum Dot-Based Electrochemical Immunosensors for Biomedical Applications.

Authors:  Bhargav D Mansuriya; Zeynep Altintas
Journal:  Materials (Basel)       Date:  2019-12-23       Impact factor: 3.623

4.  Cardiovascular magnetic resonance-determined left ventricular myocardium impairment is associated with C-reactive protein and ST2 in patients with paroxysmal atrial fibrillation.

Authors:  Lei Zhao; Songnan Li; Chen Zhang; Jie Tian; Aijia Lu; Rong Bai; Jing An; Andreas Greiser; Jie Huang; Xiaohai Ma
Journal:  J Cardiovasc Magn Reson       Date:  2021-03-22       Impact factor: 5.364

5.  Association between obstructive sleep apnea (OSA) and atrial fibrillation (AF): A dose-response meta-analysis.

Authors:  Dong Zhang; Yibo Ma; Jian Xu; Fu Yi
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.